22-09-2019

IDENTIFICATION AND EVALUATION OF RISK FACTORS AND

ASSESSING THE QUALITY OF LIFE PRE AND POST
COUNSELING IN TINEA CORPORIS PATIENTS

CHIEF INVSTIGATORS:
ADEEBA FATIMA
ANEEQUA FATIMA
B.SAI PRIYA
RESHMA SULTHANA

INTRODUCTION

1
 22-09-2019

DEFINITION:
Tinea corporis, also known as ringworm, is a superficial fungal infection
(dermatophytosis) of the arms, trunk and legs, especially on glabrous skin; however,
it may occur on any part of the body. It is similar to other forms of tinea.

CLASSIFICATION BASED ON SITES:

a) Scalp- Tinea capitis.
b) Feet- Tinea pedis/Athlete’s foot.
c) Nails- Tinea unguium /Nail infection.
d) Hands- Tinea manuum /Ring worm.
e) Groin- Tinea cruris/Jock itch.
 Body including trunk, arms and legs- Tinea corporis/Ring worm.

SIGNS AND SYMPTOMS:

Itching occurs on infected area.
The edge of the rash appears elevated and is scaly to touch.
Sometimes the skin surrounding the rash may be dry and flaky.
Almost invariably, there will be hair loss in areas of the infection.
Ringworm may cause itching or burning, especially in people with weak immune
systems.
RISK FACTORS:
Ringworm may occur in people of all ages, of all races, and of both genders.
Wear tight, constrictive clothing with poor aeration.
Participate in close contact sports.
People in frequent contact with animals.
People with weakened immune systems.

2
 22-09-2019

People who sweat heavily.

People who live in warmer, and humid climate.
The disease can also passed by person-to-person with the infected individual.
The fungus can also be spread by touching personal objects like personal care
products, bed sheets, combs, or hair brushes used by an affected person.
TREATMENT:
Most infections can be treated with prescription-strength topical creams and
lotions, including:
Terbinafine
Clotrimazole
Miconazole
Econazole
Oxiconazole

Naftifine
Ciclopirox
Ketoconazole
Sulconazole
Butenafine
Rarely, more extensive infections or those not improving with topical antifungal
medications may require 3–4 weeks of treatment with oral antifungal pills,
including:
Terbinafine
Itraconazole
Griseofulvin
Fluconazole
The ringworm should go away within 4–6 weeks after using effective treatment.

3
 22-09-2019

AIM AND
OBJECTIVES

AIM:
To identify and evaluate risk factors and assessing the quality of life pre and post
counseling in Tinea Corporis patients.

OBJECTIVES:
 To assess the risk factors for Tinea Corporis.
 To assess the improvement in Quality of life in Tinea Corporis patients.
 To provide patient counseling regarding the disease condition management and
life-style modification.
 To improve the knowledge of the patient upon his/her skin condition.

4
 22-09-2019

PLAN OF WORK:
 Selecting the department of study, topic of choice and review of the available relevant
scientific literature.
 Establishing a title and objectives of the study.
 Getting approval from the Head of the Institution.
 Getting approval from Hospital authorities.
 Designing the data collection form and selecting appropriate validated questionnaires.
 Selection of patients based on inclusion and exclusion criteria.
 Getting consent from the recruited patients.
 Collection of required information using a pre-designed data collection form and
questionnaire(s).
 Counseling the patients and recollecting the data upon follow up.
 Analyzing the data using statistical tools if required and tabulating them.
 Submitting the report.

METHODOLOGY

10

5
 22-09-2019

STUDY DESIGN: The study is designed to be a Prospective observational Study.

STUDY SITE: The study was conducted in the Department of Dermatology,
Out-Patient Block, ESI Hospital-Sanathnagar a 500 bedded secondary care
hospital located in Nacharam, Hyderabad, Telangana.
STUDY PERIOD: The study was conducted over a period of 6 months from
September 2019 to February 2020.
STUDY POPULATION:
 SAMPLE SIZE: 150-200

SUBJECT RECRUITMENT PROCEDURE:

The study subjects are selected from the Department of Dermatology, Out-Patient
Block of the hospital based on inclusion and exclusion criteria.

11

INCLUSION CRITERIA:

 Patients of both the genders.

 Patients belonging to all age groups.
 Patients with past and present diagnostic
status of Tinea Corporis.
 Patients who are willing to participate in the
study.
 Patients involved in Dermatology outpatient
department.

12

6
 22-09-2019

EXCLUSION CRITERIA:

 Patients who resist participating in the study.

 Patients with co-morbidities.
 All other types of Tinea infections.
 Pregnant and lactating women.
 Patients who are unable to answer or complete
data collection forms.
 Patients who were on any other form of
fungal infections.

13

DESIGNING DATA COLLECTION FORM:

 The present study, subjects were recruited based on inclusion and exclusion
criteria.
 The data collection form was designed to capture the demographic details and
Socioeconomic data.
 It includes essential information of patients such as: Patient name, date of visit,
age, gender, OP/IP number, address, phone number, education qualification,
Occupation, income, marital status, chief complaints, history of present illness,
past medical history, personal history- smoking habit, alcohol habit, allergies;
effected area, physical examination, risk factors, medication, duration of disease,
and reoccurrence.

14

7
 22-09-2019

SELECTION AND DESIGNING OF

QUESTIONNAIRES:
DERMATOLOGY LIFE QUALITY INDEX (DLQI)-
 The Dermatology Life Quality Index questionnaire is designed for use in adults,
i.e.
 Patients over the age of 16.
 It is self-explanatory and can be simply handed to the patient who is asked to fill
it in without the need for detailed explanation.
 It is usually completed in one or two minutes.

15

SCORING:
The scoring of each question is as follows:
 Very much scored 3.
 A lot scored 2.
 A little scored 1.
 Not at all scored 0.
 Not relevant scored 0.
 Question 7, ‘prevented work or studying’ scored 3
The DLQI is calculated by summing the score of each question resulting in a
maximum of 30 and a minimum of 0. The higher the score, the more quality of life
is impaired.

16

8
 22-09-2019

HOW TO INTERPRET MEANING OF DLQI SCORES:

 0 – 1 no effect at all on patient’s life.

 2 – 5 small effect on patient’s life.
 6 – 10 moderate effect on patient’s life.
 11 – 20 very large effect on patient’s life.
 21 – 30 extremely large effect on patient’s life.

17

DATA ANALYSIS:

 The data collected from questionnaire is to be managed and analyzed through the
SPSS software and Microsoft office excel.
 Data obtained pre and post counseling was compared and Quality of Life was
analyzed.
 Risk Factors were identified and analyzed to know the Affliction of each of them
on the patient population.

18

9
 22-09-2019

PATIENT
DATA
COLLECTIO
N FORM &
QUESTION-
NAIRE

19

20

10
 22-09-2019

21

PATIENT CONSENT FORM

22

11
 22-09-2019

PATIENT INFORMATION LEAFLET

23

PATIENT INFORMATION LEAFLET

24

12
 22-09-2019

25

26

13
 22-09-2019

27

14